Grifols Egypt for Plasma Derivatives (GEPD)
Nourhane Karaman is a Senior Talent Acquisition Specialist at Grifols Egypt for Plasma Derivatives, with a focus on managing the recruitment process and enhancing candidate experiences since October 2022. Previously, Nourhane served as a Human Resources Specialist at Hassan Allam Holding, improving policies and overseeing hiring processes from January 2022 to October 2022. From March 2017 to January 2022, Nourhane worked as a Recruitment and Development Specialist at Saipem, providing support for skill and performance evaluations. Nourhane holds a Bachelor's degree in Mass Communication/Media Studies from Ain Shams University and has furthered education through various institutions including AUC - School of Continuing Education and The Canadian Chamber of Commerce in Egypt. Nourhane is also an SAP user.
This person is not in any teams
Grifols Egypt for Plasma Derivatives (GEPD)
Grifols Egypt for plasma derivatives is a joint-venture (JV) company between the Egyptian Government, through the National Service Projects Organization (NSPO) and Grifols, the global leader in plasma medicines with more than 110 years of contribution to improving the health and well-being of people. This joint venture is the first of its kind in the plasma industry and the first-ever Egyptian source member of the Plasma Protein Therapeutics Association (PPTA). GEPD is a groundbreaking global public-private alliance that will benefit the entire region. GEPD is committed to developing the plasma medicines market and achieving self-sufficiency in these critical therapies, which is crucial for the Egyptian healthcare system. We are combining the expertise of both shareholders to build and operate 20 plasma donation centers throughout Egypt, along with manufacturing facilities including fractionation, purification, and fill-and-finish plants with a processing capacity of up to 1 million liters of plasma annually that can double in the future. The new manufacturing facility will include a plasma warehouse and a testing laboratory. It will occupy 105,000 square meters strategically located in the administrative capital’s medical city, adjoining various healthcare institutions.